Here’s what you need to know:
1. The company experienced a 4 percent revenue spike year-over-year, generating $1.25 billion for the quarter.
2. Smith & Nephew’s sports medicine, trauma and other business segment drew in the most revenue for the quarter with $502 million, a 5 percent increase year-over-year.
3. The company’s advanced wound management segment reported $329 million in revenue in the second quarter, a 4 percent increase year-over-year.
4. During the second quarter, Smith & Nephew’s reconstruction segment grew 4 percent year-over-year, topping $414 million.
5. Within the reconstruction segment, Smith & Nephew’s knee implants brought in $258 million in revenue and hip implants $156 million for the second quarter.
6. When considering geographical location, the U.S. generated the most revenue for the company with $590 million.
7. Smith & Nephew is on track for full-year underlying revenue growth to be between 2 percent and 3 percent with trading profits at or above what was achieved in 2017.
To view the full financial report, click here.
More articles on devices and implants:
Stryker reports $3.3B in Q2 sales, neurotechnology & spine segment experiences 19.4% uptick: 6 things to know
Medtronic, Titan Spine, Wright Medical & more: 9 device company notes
US House repeals sales tax on medical devices: 4 details to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
